Hematopoietic stem cell transplantation for homozygous β-thalassemia and β-thalassemia/hemoglobin E...
Hematopoietic stem cell transplantation for homozygous β-thalassemia and β-thalassemia/hemoglobin E patients from haploidentical donors
About this item
Full title
Author / Creator
Anurathapan, U , Hongeng, S , Pakakasama, S , Sirachainan, N , Songdej, D , Chuansumrit, A , Charoenkwan, P , Jetsrisuparb, A , Sanpakit, K , Rujkijyanont, P , Meekaewkunchorn, A , Lektrakul, Y , Iamsirirak, P , Surapolchai, P , Satayasai, W , Sirireung, S , Sruamsiri, R , Wahidiyat, P A , Ungkanont, A , Issaragrisil, S and Andersson, B S
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Thalassemia-free survival after allogeneic stem cell transplantation (SCT) is about 80–90% with either matched-related or -unrelated donors. We explored the use of a mismatched-related (‘haplo- ’) donor. All patients received two courses of pretransplant immunosuppressive therapy (PTIS) with fludarabine (Flu) and dexamethasone (Dxm). After two cour...
Alternative Titles
Full title
Hematopoietic stem cell transplantation for homozygous β-thalassemia and β-thalassemia/hemoglobin E patients from haploidentical donors
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4957689
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4957689
Other Identifiers
ISSN
0268-3369
E-ISSN
1476-5365
DOI
10.1038/bmt.2016.7
